>
pdufa.bio

VXA-COV2-3.3

Updated ยทnext FDA decision on the calendar

VXA-COV2-3.3 is a Vaxart, Inc. program. Its next catalyst is a Readout in May 2027. Every date links its source.

VXRT catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Vaxart, Inc. (VXRT). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · May 2027VXRT

Questions

When is VXA-COV2-3.3's next FDA decision or readout?

The next tracked catalyst for VXA-COV2-3.3 is a Readout in May 2027.

What happened at VXA-COV2-3.3's most recent FDA decision?

No FDA decision for VXA-COV2-3.3 is in our archive yet.

Who makes VXA-COV2-3.3?

Vaxart, Inc. (VXRT).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.